181 related articles for article (PubMed ID: 374652)
1. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.
Peterson PK; Schmeling D; Cleary PP; Wilkinson BJ; Kim Y; Quie PG
J Infect Dis; 1979 May; 139(5):575-85. PubMed ID: 374652
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
[TBL] [Abstract][Full Text] [Related]
3. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
5. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
[TBL] [Abstract][Full Text] [Related]
6. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.
Wilkinson BJ; Peterson PK; Quie PG
Infect Immun; 1979 Feb; 23(2):502-8. PubMed ID: 422250
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
Dale JB; Washburn RG; Marques MB; Wessels MR
Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
[TBL] [Abstract][Full Text] [Related]
8. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
[TBL] [Abstract][Full Text] [Related]
9. Role of antibody and complement in opsonization of group B streptococci.
Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
[TBL] [Abstract][Full Text] [Related]
10. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.
Yamamura M; Valdimarsson H
Immunology; 1978 Apr; 34(4):689-94. PubMed ID: 363601
[TBL] [Abstract][Full Text] [Related]
11. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
[TBL] [Abstract][Full Text] [Related]
12. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
[TBL] [Abstract][Full Text] [Related]
13. Deficient alternative complement pathway activity in newborn sera.
Mills EL; Björksteń B; Quie PG
Pediatr Res; 1979 Dec; 13(12):1341-4. PubMed ID: 392430
[TBL] [Abstract][Full Text] [Related]
14. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
Baker CJ; Edwards MS; Webb BJ; Kasper DL
J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.
Gardner SE; Anderson DC; Webb BJ; Stitzel AE; Edwards MS; Spitzer RE; Baker CJ
Infect Immun; 1982 Mar; 35(3):800-8. PubMed ID: 6802760
[TBL] [Abstract][Full Text] [Related]
16. The role of different K antigens of Escherichia coli in phagocytosis by polymorphonuclear leukocytes.
Verweij-Van Vught AM; Namavar F; Peerbooms PG; Sparrius M; Maclaren DM
J Med Microbiol; 1984 Apr; 17(2):141-50. PubMed ID: 6142958
[TBL] [Abstract][Full Text] [Related]
17. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
Van Dijk WC; Verbrugh HA; van der Tol ME; Peters R; Verhoef J
Infect Immun; 1979 Aug; 25(2):603-9. PubMed ID: 385502
[TBL] [Abstract][Full Text] [Related]
18. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.
Rainard P; Boulard C
Infect Immun; 1992 Nov; 60(11):4801-8. PubMed ID: 1398991
[TBL] [Abstract][Full Text] [Related]
19. Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus.
Spika JS; Verbrugh HA; Verhoef J
Infect Immun; 1981 Nov; 34(2):455-60. PubMed ID: 7309234
[TBL] [Abstract][Full Text] [Related]
20. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
Baltimore RS; Shedd DG
Pediatr Res; 1983 Dec; 17(12):952-8. PubMed ID: 6419197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
